Autocrine mechanisms of cancer chemoresistance

Giovanna Butera1, Raffaella Pacchiana1, Massimo Donadelli1

  • 1Department of Neurosciences, Biomedicine and Movement Sciences, Biochemistry Section, University of Verona, Verona, Italy.

Insights

Cancer cells secrete factors that promote drug resistance by altering the tumor microenvironment. Understanding these secreted molecules is key to developing new cancer therapies and biomarkers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • The cancer secretome significantly influences the tumor microenvironment.
  • Cancer cell-secreted factors contribute to therapeutic drug resistance.
  • Understanding these mechanisms is crucial for advancing cancer treatment.

Purpose of the Study:

  • To review novel findings on secreted molecules regulating cancer cell drug sensitivity.
  • To highlight cancer cell-secreted factors involved in chemoresistance.
  • To identify potential therapeutic targets and prognostic biomarkers.

Main Methods:

  • Literature review of recent studies on cancer secretome and chemoresistance.
  • Analysis of autocrine signaling pathways mediated by secreted molecules.
  • Categorization of secreted factors influencing drug sensitivity.

Main Results:

  • Cancer cells secrete various factors, including growth factors, glycoproteins, and cytokines, that induce chemoresistance.
  • Enzymes, chaperones, and tumor-derived exosomes also play a role in mediating drug resistance.
  • Autocrine signaling by these secreted molecules is a significant mechanism of chemoresistance.

Conclusions:

  • Secreted molecules from cancer cells are critical regulators of chemoresistance.
  • Targeting these secreted factors offers potential for novel anticancer strategies.
  • Secreted biomarkers hold promise for prognosis and therapeutic monitoring.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Chemotaxis and Direction of Cell Migration01:21

Chemotaxis and Direction of Cell Migration

Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
5.9K